Potentiation of anandamide hypotension by the transport inhibitor, AM404

European Journal of Pharmacology

Volumn 337, Issue 1, 1997, Pages

  Calignano, Antonio ^a   La Rana, Giovanna ^a   Beltramo, Massimiliano ^c   Makriyannis, Alexandros ^b   Piomelli, Daniele ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c NEUROSCIENCES INSTITUTE   (United States)

Author keywords

Anandamide; Cannabinoid; Vasculature

Indexed keywords

ANANDAMIDE; ANTIHYPERTENSIVE AGENT; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONYLETHANOLAMIDE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG EFFECT; DRUG TRANSPORT; GUINEA PIG; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030726945     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01297-1     Document Type: Article

References (8)

1. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 277:1997;1094.
2. Desarnaud F., Cadas H., Piomelli D. Anandamide amidohydrolase in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 270:1995;6030.
3. Devane W.A., Hanuš L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946.
4. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686.
5. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313.
6. Randall M.D., Alexander S.P.H., Bennett T., Boyd E.A., Fry J.R., Gardiner S.M., Kemp P.A., McCulloch A.I., Kendall D.A. An endogenous cannabinoid as endothelium-derived relaxant factor. Biochem. Biophys. Res. Commun. 229:1996;114.
7. Rinaldi-Carmona M., Barth M., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240.
8. Varga K., Blake K., Martin B.R., Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol. 278:1995;279.